We report on 5-month-old girl with severe autoimmune hemolytic anemia (hemoglobin 2.9 g! dl, positive direct Coombs test) in whom thrombocytopenia developed after red blood cell transfusion. The platelet count was 62.1 " 10 4 ! mm 3 on admission and rapidly fell to 6.0 " 10 4 ! mm 3 rapidly after transfusion of incompatible red blood cells with intravenous predonisolone administration. No increased hemolysis or alloimmunization was observed after transfusion.
Introduction
Autoimmune hemolytic anemia is rare in children 1 .
Evans! syndrome, which is characterized by autoimmune hemolytic anemia and thrombocytopenia (<10 " 10 4 ! mm 3 ) of unknown caused etiology, is also rare condition in children; the prognosis is variable 2, 3 . Here, we report on a 5-monthold girl with autoimmune hemolytic anemia in whom thrombocytopenia developed after incompatible red blood cell transfusion.
Patient
A 5-month-old girl was referred to our hospital because of facial pallor for 3 days before admission.
We noted that her face was extremely pale and slight jaundiced. Because hematological examination revealed severe anemia and jaundice, she was admitted ( Table 1 C r e a t i n i n e % 1 mo n o c y t e s I U/ l 4 6 As p a r t a t e a mi n o t r a n s f e r a s e g / d l 2 . 9 He mo g l o b i n I U/ l 1 4 Al a n i n e a mi n o t r a n s f e r a s e % 9 . 0 He ma t o c r i t I U/ l 1 , 5 3 0 L DH / mm 3 6 2 . 1 ×1 0 4 P l a t e l e t I U/ l 1 2 2 C r e a t i n e p h o s h p o k i n a s e % 1 . 6 R e t i c u l o c y t e I U/ l 5 Amy l a s e mg / d l 0 . 7 C -R e a c t i v e P r o t e i n mE q / l 1 3 3 Na P o s i t i v e Di r e c t C o o mb s mE q / l 5 . 2 K Ne g a t i v e I n d i r e c t C o o mb s mE q / l 9 7 C l Ta b l e 2 C h a n g e s p l a t e l e t me a n v a l u e a n d L DH 
n o n e 1 5 mg 2 0 mg 2 0 mg S t e r o i d 2 0 mg ＋ B l o o d t r a n s f u s i o n Tr e a t me n t
NA: n o t a v a i l a b l e , ＊ L DH2＜ L DH3 i n d i c a t e s p l a t e l e t c o n s u mp t i o n
transfused the least-incompatible red blood cells together with 2 mg! kg of predonisolone. The blood type of her mother, patient, and transfused blood was all A and Rh (+).
After the transfusion, her condition gradually improved. However, the next day, the platelet count fell from 62.1 to 6.0 " 10 4 ! mm 3 . Thrombocytopenia (range, 6!9 " 10 4 ! mm 3 ) with increased mean platelet volume (MPV; 10.4 fL) continued until day 7 of admission ( Table 2 ). The lactate dehydrogenase (LDH) isozymes also showed a LDH2<LDH3 pattern, suggesting platelet consumption ( Table 2 ). However, she did exhibit any bleeding tendency, such as purpura. Bone marrow examination on day 7 after admission revealed moderate hypercellularity with increased numbers of erythroblasts and normal to small sized megakaryocytes without abnormal cells (Fig. 1) . On day 7, although direct Coombs! test was negative, the platelet count remained low ( Table 2) .
Anti-DNA antibody and anti-nuclear antibody were negative and values of C3, C4, and CH50 were normal. After 9 days of predonisolone therapy, the platelet count was increased with decreases in MPV to 8.0 fL along with increased hemoglobin levels. Table 2) , and the number of megakaryocytes.
These results strongly suggest that the thrombocytopenia in our patient was caused by platelet consumption 14, 15 .
Complications, such as massive hemolysis, are also rare of the transfusion of incompatible blood in patients with autoimmune hemolytic anemia 6, 11, 12 .
Hemolysis might depend on the number of antibodies on the surfaces of red blood cells. If the same phenomenon occurred in our patient!s platelets, it is reasonable to conclude that the amount of autoantibody on the platelets was a factor in consumption thrombocytopenia induced by incompatible blood transfusion. However, we could not find any report on the relationship between platelet consumption and blood transfusion in autoimmune hemolytic anemia 4"13,16 . In this report, we must, therefore, consider thrombocytopenia as an additional complications of incompatible blood transfusion in patients with autoimmune hemolytic anemia.
